MONTE ROSA THERAPEUTICS
GLUE Insider Trades:
all
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-06-03
2025-06-04
DUNN EDMUND
Principal Accounting Officer
S - Sale
Common Stock
-2,062
$4.00
-8,248
1
$276.18M
2025-01-02
2025-01-06
CHAMPOUX JENNIFER
Chief Operating Officer
A - Grant
Stock Option (Right to Buy)
135K
$0.00
1
$276.18M
2025-01-02
2025-01-06
CHAMPOUX JENNIFER
Chief Operating Officer
A - Grant
Common Stock
30,000
1
$276.18M
2025-01-02
2025-01-06
DUNN EDMUND
Principal Accounting Officer
A - Grant
Stock Option (Right to Buy)
53,400
$0.00
1
$276.18M
2025-01-02
2025-01-06
CHAMPOUX JENNIFER
Chief Operating Officer
A - Grant
Stock Option (Right to Buy)
135K
$0.00
1
$276.18M
2025-01-02
2025-01-06
CHAMPOUX JENNIFER
Chief Operating Officer
A - Grant
Common Stock
30,000
1
$276.18M
2025-01-02
2025-01-06
DUNN EDMUND
Principal Accounting Officer
A - Grant
Stock Option (Right to Buy)
53,400
$0.00
1
$276.18M
2025-01-02
2025-01-06
JANKU FILIP
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
161K
$0.00
1
$276.18M
2025-01-02
2025-01-06
NICKSON PHILIP
Chief Business & Legal Officer
A - Grant
Stock Option (Right to Buy)
161K
$0.00
1
$276.18M
2025-01-02
2025-01-06
TOWNSON SHARON
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
161K
$0.00
1
$276.18M
2025-01-02
2025-01-06
WARMUTH MARKUS
President & CEO
A - Grant
Stock Option (Right to Buy)
575K
$0.00
1
$276.18M
2025-01-02
2025-01-06
CHAMPOUX JENNIFER
Chief Operating Officer
A - Grant
Stock Option (Right to Buy)
135K
$0.00
1
$276.18M
2025-01-02
2025-01-06
CHAMPOUX JENNIFER
Chief Operating Officer
A - Grant
Common Stock
30,000
1
$276.18M
2025-01-02
2025-01-06
DUNN EDMUND
Principal Accounting Officer
A - Grant
Stock Option (Right to Buy)
53,400
$0.00
1
$276.18M
2025-01-02
2025-01-06
JANKU FILIP
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
161K
$0.00
1
$276.18M
2025-01-02
2025-01-06
WARMUTH MARKUS
President & CEO
A - Grant
Stock Option (Right to Buy)
575K
$0.00
1
$276.18M
2025-01-02
2025-01-06
JANKU FILIP
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
161K
$0.00
1
$276.18M
2025-01-02
2025-01-06
NICKSON PHILIP
Chief Business & Legal Officer
A - Grant
Stock Option (Right to Buy)
161K
$0.00
1
$276.18M
2025-01-02
2025-01-06
NICKSON PHILIP
Chief Business & Legal Officer
A - Grant
Common Stock
36,000
1
$276.18M
2025-01-02
2025-01-06
TOWNSON SHARON
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
161K
$0.00
1
$276.18M
2025-01-02
2025-01-06
WARMUTH MARKUS
President & CEO
A - Grant
Stock Option (Right to Buy)
575K
$0.00
1
$276.18M
2025-01-02
2025-01-06
NICKSON PHILIP
Chief Business & Legal Officer
A - Grant
Common Stock
36,000
1
$276.18M
2025-01-02
2025-01-06
NICKSON PHILIP
Chief Business & Legal Officer
A - Grant
Stock Option (Right to Buy)
161K
$0.00
1
$276.18M
2025-01-02
2025-01-06
NICKSON PHILIP
Chief Business & Legal Officer
A - Grant
Common Stock
36,000
1
$276.18M
2025-01-02
2025-01-06
TOWNSON SHARON
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
161K
$0.00
1
$276.18M
2024-10-29
2024-10-30
VERSANT VENTURE CAPITAL VI, L.P.
S - Sale
Common Stock
-67,905
$9.00
-611K
2
$276.18M
2024-10-28
2024-10-30
VERSANT VENTURE CAPITAL VI, L.P.
S - Sale
Common Stock
-89,990
$10.00
-900K
1
$276.18M
2024-09-20
2024-09-24
VERSANT VENTURE CAPITAL VI, L.P.
S - Sale
Common Stock
-1.13M
$7.00
-7.93M
1
$276.18M
2024-09-13
2024-09-13
JANKU FILIP
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
30,000
$0.00
1
$276.18M
2024-09-13
2024-09-13
VERSANT VENTURE CAPITAL VI, L.P.
S - Sale
Common Stock
-9,269
$6.00
-55,614
1
$276.18M
2024-09-12
2024-09-13
VERSANT VENTURE CAPITAL VI, L.P.
S - Sale
Common Stock
-16,047
$6.00
-96,282
1
$276.18M
2024-09-11
2024-09-13
VERSANT VENTURE CAPITAL VI, L.P.
S - Sale
Common Stock
-542K
$6.00
-3.25M
1
$276.18M
2024-07-05
2024-07-09
DUNN EDMUND
Principal Accounting Officer
S - Sale
Common Stock
-1,610
$4.00
-6,440
1
$276.18M
2024-06-03
2024-06-05
CHAMPOUX JENNIFER
Chief Operating Officer
A - Grant
Stock Option (Right to Buy)
40,000
$0.00
1
$276.18M
2024-06-03
2024-06-05
NICKSON PHILIP
Chief Business & Legal Officer
A - Grant
Stock Option (Right to Buy)
40,000
$0.00
1
$276.18M
2024-06-03
2024-06-05
TOWNSON SHARON
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
40,000
$0.00
1
$276.18M
2024-06-03
2024-06-05
DUNN EDMUND
Principal Accounting Officer
S - Sale
Common Stock
-1,207
$4.00
-4,828
1
$276.18M
2024-01-02
2024-01-04
WALLACE OWEN
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
119K
$0.00
1
$276.18M
2024-01-02
2024-01-04
DUNN EDMUND
Principal Accounting Officer
A - Grant
Stock Option (Right to Buy)
60,900
$0.00
2
$276.18M
2024-01-02
2024-01-04
JANKU FILIP
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
121K
$0.00
1
$276.18M
2024-01-02
2024-01-04
JONES JULLIAN
Chief Business Officer
A - Grant
Stock Option (Right to Buy)
79,000
$0.00
1
$276.18M
2024-01-02
2024-01-04
NICKSON PHILIP
General Counsel
A - Grant
Stock Option (Right to Buy)
109K
$0.00
1
$276.18M
2024-01-02
2024-01-04
WARMUTH MARKUS
President & CEO
A - Grant
Stock Option (Right to Buy)
346K
$0.00
1
$276.18M
2023-01-03
2023-01-04
CASTLE JOHN
Chief Data Scientist
A - Grant
Stock Option (Right to Buy)
78,500
$0.00
1
$276.18M
2023-01-03
2023-01-04
JANKU FILIP
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
135K
$0.00
1
$276.18M
2023-01-03
2023-01-04
JONES JULLIAN
Chief Business Officer
A - Grant
Stock Option (Right to Buy)
77,450
$0.00
1
$276.18M
2023-01-03
2023-01-04
NICKSON PHILIP
General Counsel
A - Grant
Stock Option (Right to Buy)
124K
$0.00
1
$276.18M
2023-01-03
2023-01-04
TAMBOLI AJIM
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
130K
$0.00
1
$276.18M
2023-01-03
2023-01-04
TOWNSON SHARON
Chief Technology Officer
A - Grant
Stock Option (Right to Buy)
78,550
$0.00
1
$276.18M
2023-01-03
2023-01-04
WALLACE OWEN
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
135K
$0.00
1
$276.18M
2023-01-03
2023-01-04
WARMUTH MARKUS
President & CEO
A - Grant
Stock Option (Right to Buy)
472K
$0.00
1
$276.18M
2022-12-15
2022-12-19
JANKU FILIP
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
36,000
$0.00
1
$276.18M
2022-10-31
2022-11-01
JANKU FILIP
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
36,000
$0.00
1
$276.18M
2022-03-01
2022-03-02
NICKSON PHILIP
General Counsel
A - Grant
Stock Option (Right to Buy)
70,600
$0.00
1
$276.18M
2022-03-01
2022-03-02
JONES JULLIAN
Chief Business Officer
A - Grant
Stock Option (Right to Buy)
73,300
$0.00
1
$276.18M
2022-03-01
2022-03-02
CASTLE JOHN
Chief Data Scientist
A - Grant
Stock Option (Right to Buy)
53,700
$0.00
1
$276.18M
2022-03-01
2022-03-02
JANKU FILIP
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
86,500
$0.00
1
$276.18M
2022-03-01
2022-03-02
TAMBOLI AJIM
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
112K
$0.00
1
$276.18M
2022-03-01
2022-03-02
TOWNSON SHARON
Chief Technology Officer
A - Grant
Stock Option (Right to Buy)
70,000
$0.00
1
$276.18M
2022-03-01
2022-03-02
WALLACE OWEN
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
117K
$0.00
1
$276.18M
2022-03-01
2022-03-02
WARMUTH MARKUS
President & CEO
A - Grant
Stock Option (Right to Buy)
316K
$0.00
1
$276.18M
2021-06-28
2021-06-30
BEHBAHANI ALI
C - Conversion
Series C convertible preferred Stock
-2.36M
1
$276.18M
2021-06-28
2021-06-30
CORMORANT ASSET MANAGEMENT, LP
P - Purchase
Common Stock
600K
$19.00
11M
1
$276.18M
2021-06-28
2021-06-30
NEW ENTERPRISE ASSOCIATES 17, L.P.
P - Purchase
Common Stock
1.05M
$19.00
20M
1
$276.18M
2021-06-28
2021-06-30
VERSANT VENTURE CAPITAL VI, L.P.
P - Purchase
Common Stock
158K
$19.00
3.00M
1
$276.18M
2021-06-28
2021-06-30
BASKETT FOREST
C - Conversion
Series A-2 convertible preferred stock
-9.59M
1
$276.18M
2021-06-28
2021-06-30
BASKETT FOREST
C - Conversion
Series B convertible preferred stock
-12M
1
$276.18M
2021-06-28
2021-06-30
BASKETT FOREST
C - Conversion
Series C convertible preferred Stock
-2.36M
1
$276.18M
2021-06-28
2021-06-30
BEHBAHANI ALI
C - Conversion
Series A-2 convertible preferred stock
-9.59M
1
$276.18M
2021-06-28
2021-06-30
BEHBAHANI ALI
C - Conversion
Series B convertible preferred stock
-12M
1
$276.18M
2021-06-28
2021-06-30
BOLZON BRADLEY PHD
C - Conversion
Series A convertible preferred stock
-20M
1
$276.18M
2021-06-28
2021-06-30
BOLZON BRADLEY PHD
C - Conversion
Series B convertible preferred stock
-7.15M
2
$276.18M
2021-06-28
2021-06-30
BOLZON BRADLEY PHD
C - Conversion
Series C convertible preferred stock
-2.70M
1
$276.18M
2021-06-28
2021-06-30
CHANG CARMEN
C - Conversion
Series A-2 convertible preferred stock
-9.59M
1
$276.18M
2021-06-28
2021-06-30
CHANG CARMEN
C - Conversion
Series C convertible preferred Stock
-2.36M
1
$276.18M
2021-06-28
2021-06-30
CORMORANT ASSET MANAGEMENT, LP
C - Conversion
Series B Convertible Preferred Stock
2.12M
1
$276.18M
2021-06-28
2021-06-30
CORMORANT ASSET MANAGEMENT, LP
C - Conversion
Series C Convertible Preferred Stock
478K
1
$276.18M
2021-06-28
2021-06-30
FLORENCE ANTHONY JR.
C - Conversion
Series A-2 convertible preferred stock
-9.59M
1
$276.18M
2021-06-28
2021-06-30
FLORENCE ANTHONY JR.
C - Conversion
Series B convertible preferred stock
-12M
1
$276.18M
2021-06-28
2021-06-30
FLORENCE ANTHONY JR.
C - Conversion
Series C convertible preferred Stock
-2.36M
1
$276.18M
2021-06-28
2021-06-30
LANDSMAN LIZA
C - Conversion
Series A-2 convertible preferred stock
-9.59M
1
$276.18M
2021-06-28
2021-06-30
LANDSMAN LIZA
C - Conversion
Series B convertible preferred stock
-12M
1
$276.18M
2021-06-28
2021-06-30
LANDSMAN LIZA
C - Conversion
Series C convertible preferred Stock
-2.36M
1
$276.18M
2021-06-28
2021-06-30
MAKHZOUMI MOHAMAD
C - Conversion
Series A-2 convertible preferred stock
-9.59M
1
$276.18M
2021-06-28
2021-06-30
MAKHZOUMI MOHAMAD
C - Conversion
Series B convertible preferred stock
-12M
1
$276.18M
2021-06-28
2021-06-30
MAKHZOUMI MOHAMAD
C - Conversion
Series C convertible preferred Stock
-2.36M
1
$276.18M
2021-06-28
2021-06-30
MAKOWER JOSHUA
C - Conversion
Series A-2 convertible preferred stock
-9.59M
1
$276.18M
2021-06-28
2021-06-30
MAKOWER JOSHUA
C - Conversion
Series B convertible preferred stock
-12M
1
$276.18M
2021-06-28
2021-06-30
MAKOWER JOSHUA
C - Conversion
Series C convertible preferred Stock
-2.36M
1
$276.18M
2021-06-28
2021-06-30
MATHERS EDWARD
C - Conversion
Series A-2 convertible preferred stock
-9.59M
1
$276.18M
2021-06-28
2021-06-30
MATHERS EDWARD
C - Conversion
Series B convertible preferred stock
-12M
1
$276.18M
2021-06-28
2021-06-30
MATHERS EDWARD
C - Conversion
Series C convertible preferred Stock
-2.36M
1
$276.18M
2021-06-28
2021-06-30
NEW ENTERPRISE ASSOCIATES 17, L.P.
C - Conversion
Series A-2 convertible preferred stock
-9.59M
1
$276.18M
2021-06-28
2021-06-30
NEW ENTERPRISE ASSOCIATES 17, L.P.
C - Conversion
Series B convertible preferred stock
-12M
1
$276.18M
2021-06-28
2021-06-30
NEW ENTERPRISE ASSOCIATES 17, L.P.
C - Conversion
Series C convertible preferred Stock
-2.36M
1
$276.18M
2021-06-28
2021-06-30
SANDELL SCOTT
C - Conversion
Series A-2 convertible preferred stock
-9.59M
1
$276.18M
2021-06-28
2021-06-30
SANDELL SCOTT
C - Conversion
Series B convertible preferred stock
-12M
1
$276.18M
2021-06-28
2021-06-30
SANDELL SCOTT
C - Conversion
Series C convertible preferred Stock
-2.36M
1
$276.18M
2021-06-28
2021-06-30
SONSINI PETER
C - Conversion
Series A-2 convertible preferred stock
-9.59M
1
$276.18M
2021-06-28
2021-06-30
SONSINI PETER
C - Conversion
Series B convertible preferred stock
-12M
1
$276.18M
2021-06-28
2021-06-30
SONSINI PETER
C - Conversion
Series C convertible preferred Stock
-2.36M
1
$276.18M
2021-06-28
2021-06-30
VERSANT VENTURE CAPITAL VI, L.P.
C - Conversion
Series A convertible preferred stock
-20M
1
$276.18M
2021-06-28
2021-06-30
VERSANT VENTURE CAPITAL VI, L.P.
C - Conversion
Series B convertible preferred stock
-7.15M
2
$276.18M
2021-06-28
2021-06-30
VERSANT VENTURE CAPITAL VI, L.P.
C - Conversion
Series C convertible preferred stock
-2.70M
1
$276.18M
2021-06-28
2021-06-30
WALKER PAUL EDWARD
C - Conversion
Series A-2 convertible preferred stock
-9.59M
1
$276.18M
2021-06-28
2021-06-30
WALKER PAUL EDWARD
C - Conversion
Series B convertible preferred stock
-12M
1
$276.18M
2021-06-28
2021-06-30
WALKER PAUL EDWARD
C - Conversion
Series C convertible preferred Stock
-2.36M
1
$276.18M
2021-06-28
2021-06-30
YANG RICK
C - Conversion
Series A-2 convertible preferred stock
-9.59M
1
$276.18M
2021-06-23
2021-06-25
JANKU FILIP
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
387K
$0.00
1
$276.18M
2021-06-23
2021-06-25
TAMBOLI AJIM
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
56,649
$0.00
1
$276.18M
2021-06-23
2021-06-25
WALLACE OWEN
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
113K
$0.00
1
$276.18M
2021-06-23
2021-06-25
WARMUTH MARKUS
President & Chief Executive Of...
A - Grant
Stock Option (Right to Buy)
142K
$0.00
1
$276.18M
2021-04-12
2021-06-25
WALLACE OWEN
Chief Scientific Officer
A - Grant
Stock Option (Right to Buy)
387K
$0.00
1
$276.18M
2021-04-12
2021-06-25
WARMUTH MARKUS
President & Chief Executive Of...
A - Grant
Stock Option (Right to Buy)
539K
$0.00
1
$276.18M
2021-04-12
2021-06-25
TAMBOLI AJIM
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
101K
$0.00
1
$276.18M
2021-03-11
2021-06-25
BOLZON BRADLEY PHD
A - Grant
Series C convertible preferred stock
2.70M
$3.00
8.10M
1
$276.18M
2021-02-24
2021-06-25
BOLZON BRADLEY PHD
A - Grant
Series B convertible preferred stock
3.58M
$2.00
7.15M
2
$276.18M